Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated chemistry analyzers; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; total laboratory automation system; mass spectrometry; and, blood lipid subfraction analyzer, and POCT.It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly known as Ningbo Medicalsystem Biotechnology Co., Ltd. and changed its name to Biotechnology Co., Ltd. in January 2017. Medicalsystem Biotechnology Co., Ltd. was founded in 2003 and is based in Ningbo, China.
Frequently asked questions
What sector does Ningbo MedicalSystem Biotechnology Co Ltd (300439) operate in?
Ningbo MedicalSystem Biotechnology Co Ltd belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Ningbo MedicalSystem Biotechnology Co Ltd (300439) current stock price?
As of the latest data, Ningbo MedicalSystem Biotechnology Co Ltd stock price is CN¥9.27, with a previous close of CN¥9.14. Ningbo MedicalSystem Biotechnology Co Ltd gained CN¥0.13 in the last trading session, representing a 1.42% increase.
What is Ningbo MedicalSystem Biotechnology Co Ltd (300439) current market capitalization?
Ningbo MedicalSystem Biotechnology Co Ltd market cap is approximately 3.56 billion.
What is Ningbo MedicalSystem Biotechnology Co Ltd (300439) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.17.
What is Ningbo MedicalSystem Biotechnology Co Ltd (300439) Price-to-Earnings (P/E) ratio?
Ningbo MedicalSystem Biotechnology Co Ltd current P/E ratio is 54.53.
Does Ningbo MedicalSystem Biotechnology Co Ltd (300439) pay dividends?
Yes. Ningbo MedicalSystem Biotechnology Co Ltd pays annual dividends with an annualized yield of 0.36% and an estimated annual payout of CN¥0.03 per share.
When is the next ex-dividend date for Ningbo MedicalSystem Biotechnology Co Ltd (300439)?
The next ex-dividend date is scheduled for June 11, 2027.
What is Ningbo MedicalSystem Biotechnology Co Ltd (300439) beta (volatility) score?
Ningbo MedicalSystem Biotechnology Co Ltd has a beta of 0.268, indicating lower volatility than the overall market.